- Report
- April 2020
- 150 Pages
Global
From €6205EUR$6,950USD£5,428GBP
- Report
- July 2024
- 151 Pages
Global
From €3794EUR$4,250USD£3,319GBP
- Report
- August 2022
- 135 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- June 2024
- 200 Pages
Global
From €7097EUR$7,950USD£6,209GBP
- Report
- April 2025
- 139 Pages
From €3080EUR$3,450USD£2,695GBP
- Report
- January 2023
- 156 Pages
Europe
From €3080EUR$3,450USD£2,695GBP
- Report
- October 2022
- 209 Pages
Global
From €3973EUR$4,450USD£3,476GBP
- Report
- September 2022
- 157 Pages
Europe
From €3080EUR$3,450USD£2,695GBP
- Report
- July 2022
- 132 Pages
Europe
From €3080EUR$3,450USD£2,695GBP
- Report
- July 2022
- 122 Pages
United Kingdom
From €3080EUR$3,450USD£2,695GBP
- Report
- March 2022
- 198 Pages
Global
From €3973EUR$4,450USD£3,476GBP
- Report
- April 2023
- 114 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- April 2023
- 112 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- April 2023
- 107 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- April 2023
- 102 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- April 2023
- 116 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- April 2023
- 114 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- April 2023
- 120 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- April 2023
- 115 Pages
Global
From €4241EUR$4,750USD£3,710GBP
- Report
- April 2023
- 114 Pages
Global
From €4241EUR$4,750USD£3,710GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more